References
- Hankins J R, Mayer R F, Satterfield J R, et al. Thymectomy for myasthenia gravis: 14-year experience. Ann Surg 1985; 201(5)618–125
- Appelqvist P, Kostiainen S, Franssila K, et al. Treatment and prognosis of thymoma: a review of 25 cases. J Surg Oncol 1982; 20: 265–268
- Prior P, Symmons D PM, Hawkins C F, Scott D L. Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis 1984; 43: 128–136
- Miller R W. Genetically determined immunodeficiency diseases and malignancy. Child Cancer Etiol News No. 57 March 15, 1979
- Limburg P C, The T H, Hummel-Tappel E, Oosterhuis H J. Antiacetylcholine receptor antibodies in myasthenia gravis. J Neurol Sci 1983; 58: 357–370
- The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Cancer 1982; 49: 2112–2135
- Hsu S M, Racine L, Fauger H. A comparative study of PAP method and avidin-biotin-peroxidase method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981; 75: 734–738
- Tawa A, Hozumi N, Minden M, Mak T W. Rearrangement of the T-cell receptor B-chain gene in non-T-cell, non-B-cell acute lymphoblastic leukemia of childhood. N Engl J Med 1985; 313: 1033–1037
- Sternberg C. Leukosakomatose and Myeloblastenleukaamie. Beitr Pathol 1916; 61: 75–100
- Nathwani B N, Diamond L W, Winberg C D, et al. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer 1981; 48: 2347–2357
- Smith J L, Barker C R, Clein G P, Collins R D. Characterization of malignant mediastinal lymphoid neoplasms (Sternberg sarcoma) as thymic in origin. Lancet 1973; 1: 74–77
- Rosai J, Levin G D. Tumors of the Thymus. Armed Forces Institute of Pathology, Washington, DC 1976
- Levine G, Rosai J. Thymic hyperplasia and neoplasia: A review of current concepts. Human Pathol 1978; 9: 495–515
- Chilosi M, Ianucci A M, Pizzolo G, et al. Immunohistochemical analysis of thymoma. Am J Surg Pathol 1984; 8: 309–318
- Mokhtar N, Hsu S, Lad R P, et al. Thymoma: lymphoid and epithelial components mirror the phenotype of normal thymus. Human Pathol 1984; 15: 378–384
- Van der Kevast T H, Van Vliet E, Cristen E, et al. An immunologic study of the epithelial and lymphoid components of six thymomas. Human Pathol 1985; 16: 1001–1008
- Kornstein M J, Hoxie J A, Levinson A L, Brooks J J. Immuno-histology of human thymomas. Arch Pathol Lab Med 1985; 109: 460–463
- Kadin M E. T cell malignancies: Can pathologic and clinical features be prediced from the tumor cell phenotype?. UT MD Anderson Conference on Cancer 1984; 27: 249–262
- Crossman L. Diversity of immunologic phenotypes of T cell lymphomas. Am J Surg Pathol 1982; 6: 72
- Simpson J A. Myasthenia gravis as an autoimmune disease: clinical aspects. Ann NY Acad Sci 1966; 1335: 506–516
- Silberstein E B. Myasthenia gravis, hemolytic anemia and lym-phoreticular malignancy. Br J Med 1970; 3: 445–446
- Levo Y, Knott E, Atsmon A. Association between myasthenia gravis and malignant lymphoma. Eur Neurol 1975; 13: 245–250
- Papatestas A E, Osserman K E, Kark A E. The relationship between thymus and oncogenesis: A study of the incidence of non-thymic malignancy in myasthenia gravis. Br J Cancer 1971; 25: 635–645
- Null J A, Livolsi V A, Glenn W WL. Hodgkin's disease of the thymus (Granulomatous thymoma) and myasthenia gravis. Am J Clin Pathol 1977; 67: 55–58
- Hansen B A, Sorenson P S, Lauritzen M J, et al. A case of malignant lymphoma and myasthenia gravis. Scand J Haematol 1983; 31: 155–160
- Davis S, Schumacher M J. Myasthenia gravis and lymphoma. JAMA 1979; 242: 2096–2097
- Ingram Da, Davis G R, Swartz M S, et al. Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment. J Neurol Neurosurg Psychol 1984; 47: 806–812
- Eaton L M, Lambert E H. Electromyography and electric stimulation of nerves in diseases of motor unit: observations of myasthenic syndrome associated with malignant tumors. JAMA 1957; 1117–1124
- Keesey J, Naiem F, Lindstrom J, Roe D, Herrmann C, Walford R. Acetylcholine receptor antibody titre and HLA-8 antigen in myasthenia gravis. Arch Neurol 1982; 39: 73–77